LYFAZIT Trademark

Trademark Overview

On Friday, September 20, 2013, a trademark application was filed for LYFAZIT with the United States Patent and Trademark Office. The USPTO has given the LYFAZIT trademark a serial number of 86070196. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 22, 2021. This trademark is owned by Takeda Pharmaceutical Company Limited. The LYFAZIT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of diabetic diseases
lyfazit

General Information

Serial Number86070196
Word MarkLYFAZIT
Filing DateFriday, September 20, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 22, 2021
Registration Number4550730
Registration DateTuesday, June 17, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2014

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 8, should be deleted, and PRIORITY CLAIMED SEC. 44(D) ON JAPAN APPLICATION NO. 2013-029590, FILED 4-19-2013, REG. NO. 5616594, DATED 9-20-2013, EXPIRES 9-20-2023 should be inserted.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of diabetic diseases
Translation of Words in MarkThe wording "LYFAZIT" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTakeda Pharmaceutical Company Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP

Trademark Events

Event DateEvent Description
Friday, January 22, 2021CANCELLED SEC. 8 (6-YR)
Tuesday, July 7, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 17, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 22, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 11, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 21, 2014CORRECTION UNDER SECTION 7 ¿ PROCESSED
Thursday, August 21, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 17, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, April 1, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 1, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, February 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 5, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 5, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 3, 2014ASSIGNED TO LIE
Friday, January 24, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 29, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 29, 2013NON-FINAL ACTION E-MAILED
Sunday, December 29, 2013NON-FINAL ACTION WRITTEN
Sunday, December 29, 2013ASSIGNED TO EXAMINER
Friday, September 27, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 24, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

lyfazit diabetic diseases prevention treatment preparations pharmaceutical